Other notable targets include PLN (phospholamban), involved in calcium handling abnormalities in dilated cardiomyopathy (DCM), and RBM20, a gene associated with RNA splicing defects in heart failure. The gene discussed is RBM20; the disease is dilated cardiomyopathy.